On Wednesday, March 15, at 12 p.m. EST, the Accelerate Cure/Treatments for Alzheimer’s Disease (ACT-AD) Coalition will hold a one-hour webinar on symptomatic relief for Alzheimer’s disease. The webinar will feature experts who discuss the burden of Alzheimer’s disease on patients and their families, advances in neurobiology, and provide an update on clinical development activities to improve the treatment of Alzheimer’s disease symptoms.
Featured experts will include:
Jeffrey L. Cummings, M.D., Sc.D., Director, Lou Ruvo Center for Brain Health, Camille and Larry Ruvo Chair for Brain Health, Cleveland Clinic
Richard Malamut, M.D., Chief Medical Officer, Senior Vice President, Research & Development, Avanir Pharmaceuticals
Joan Amatniek, M.D., Msc, Senior Director, CNS, Global Clinical Development, Otsuka Pharmaceutical
Cynthia A. Bens, Executive Director, Accelerate Cure/Treatments for Alzheimer’s Disease (ACT-AD)
